Chronic hepatitis B is a viral infection that can currently only be treated ... treatment of HBV infection that displays a highly specific antiviral inhibition of capsid formation, concomitant with a ...

Hepatitis B can lead to liver disease. But we can prevent and manage this viral infection. Here’s what we know about the ...

At least one-third of the world's population has been infected with the hepatitis B virus (HBV), and 400 million people are chronic carriers. In most populations, chronic HBV infection is the ...

Currently, we are focused on the hepatitis B virus capsid, the cytoplasmic dynein motor domain, and the role of carbohydrates and glycoconjugates in immunity and disease. "Assembly properties of ...

license agreement with Emory University to provide hepatitis B virus capsid assembly modulator technology; license agreement with Luxna Biotech Co., Ltd. to develop and commercialize products ...

Unlike inactivated, subunit or recombinant protein vaccines (such as those against diphtheria, pertussis, tetanus, hepatitis B virus and flu ... for the capsid protein P1, was recoded with ...